• Bruker Daltonics (Billerica, Massachusetts) said its new ClinProt Micro solution is being showcased at this week’s American Association for Cancer Research meeting in Ana-heim, California. The company said the ClinProt Micro is an easy-to-use and compact clinical system dedicated to peptide and protein profiling, biomarker discovery and biomarker validation (currently for research use only). It is based on a high-performance bench-top MALDI-TOF mass spectrometer from Bruker Daltonics’ FLEX series, providing the reliability and reproducibility needed for rigorous validation studies of putative biomarkers for cancer and other diseases. The ClinProt Micro system offers integrated sample preparation tools for biofluids and tissue extracts with comprehensive analysis, visualization and model-building software.